Abcam will not pursue Horizon Discovery

Abcam Plc has decided not to pursue a proposed offer for Horizon Discovery Group Plc having been rebuffed by the gene-editing company, which is based in Cambridge, UK. Abcam is a pharmaceutical services company, also based in Cambridge.

Full text available to subscribers only. Click here for information on subscribing to MedNous.


United Kingdom